A new U.S. study found Anoro Elipta to be better than Bevespi Aerosphere or Stiolto Respimat at lowering the risk of disease flares in COPD.
Poster presented to medical and drug industry conferees at prestigious American Academy of Allergy, Asthma & Immunology (AAAAI) Annual MeetingResearch demonstrates the technology’s ability to identify ...
PRIME recognition underscores potential of inhaled RNA therapy to address unmet need in patients with the 3849+10Kb C>T mutationCompany advancing ...
Nutrition is more than just calories, carbohydrates and protein; it can be a powerful tool in managing lung disease and ...
Chronic obstructive pulmonary disease (COPD) presents core pathological changes that current medications cannot reverse. Mesenchymal stromal cell (MSC) transplantation has shown therapeutic potential ...
We are exposed to air pollution daily. When we step outside, we inhale pollutants from particulate matter (such as smoke or dust), burning fossil fuels, wildfires and more. For Lung Cancer Awareness ...
Background: Diagnosing acute exacerbation of chronic obstructive pulmonary disease (AECOPD) remains challenging in clinical practice. Computed tomography (CT) plays a great role in characterizing and ...
A genetically modified pig lung remained viable and functional over a period of 9 days after being transplanted into a human recipient who had been declared brain dead, according to research published ...
Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) than the general population. Among IBD patients, women, older adults, and ...
– The pivotal Phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualized exacerbation rate (AER) at 52 weeks when astegolimab was given every two weeks ...
This educational activity is intended for pulmonary specialists and other members of the health care team who care for patients with obstructive lung diseases such as COPD and asthma. Asthma and COPD ...